Gelesis is at the forefront of biomimicry-based therapeutics, developing therapies based on our OSH patented hydrogel platform inspired by nature. Our comprehensive research spans from fundamental technology development to clinical applications, with ongoing studies in multiple therapeutic areas.
Discover our novel OSH hydrogel technology platform, proven by a rigorous mechanism.
View our current and future pipeline of therapeutic candidates targeting obesity and GI-related chronic diseases. Track our progress from preclinical to clinical stages.
Access our peer-reviewed publications, scientific posters, and conference presentations. Stay updated on our latest research findings and clinical data.